Abstract:Objective To investigate the clinical risk factors related to the cirrhosis development in patients with hepatitis B virus infection. Methods A total of 988 participants with hepatitis B virus infection were collected for this study in Zhong Shan Hospital affiliated with Fu Dan University between January 2009 and January 2011. All of them were Chinese Han nationality from Shanghai and its surrounding area. Their information, including hepatitis history, serum test, liver imaging, and liver histology if available, were collected. They were divided into healthy recovered and chronic hepatitis group, the later was subdivided into cirrhotic group and non-cirrhotic group. The general informations and clinical determination datas were compared with statistical analysis by using SPSS 18.0 and STATA 11.0 software. Results (1) The ratio of male/female participants was 736/252, and the average age was 50.8±13.2. The numbers of participants in healthy recovered group, non-cirrhotic chronic hepatitis and cirrhotic group were 274, 285, and 429, respectively, and the average ages were 56.7±13.6, 49.2±11.5, and 47.5±13.5, respectively. Chronic hopatitis B (CHB) familial history was found in 2.2% participants of the healthy recovered group and 47.5% participants of chronic hepatitis group. The vertical infection rates were 56.3% in healthy recovered group, and 93.7% in chronic hepatitis group, which have significant difference between them. For chronic hepatitis group, the vertical rates of non-cirrhotic and cirrhotic group were 89.4% and 96.4%, respectively, which also have significant difference between them. The vertical infection was a risk factor for chronicity of hepatitis B (OR=15.02, 95% CI:9.57-23.94) and the development of cirrhosis (OR=3.15, 95%CI:1.39-7.45). The duration of disease of cirrhotic patients (44.1±9.5 years) was longer than that of non-cirrhotic CHB patients (39.3±9.8 years). The ratio of male patients in cirrhotic group was also significantly higher than that in non-cirrhotic group (70.2%) and the duration of disease for male patients (41.7±9.3 years) were shorter than that of female patients (45.0±11.4 years).(2) The levels of liver function rests were significantly different among healthy recover, non-cirrhotic, and cirrhotic group of CHB patients. There were negative correlation between HBsAg and HBV DNA in HBeAg positive patients (r=-0.43);However positive correlation in HBeAg negative patients (r=0.23) was observed. HBsAg level, which was higher than 1 000 COI, of cirrhotic patients (89.5%) was significant higher than that of non-cirrhotic patients (89.5%) (OR=1.86, 95% CI:1.18-2.94). No correlation was found betweem HBV DNA level and the duration of disease of CHB (P=0.21). Although HBV DNA level in cirrhotic group was significantly higher than that in non-cirrhotic group (2.875±2.68 log10copies/mL), the ratio of patients with HBV DNA level, which was higher than 5 log10copies/mL in cirrhotic group (31%) was significantly lower than that in non-cirrhotic group(57.2%). Conclusion The factors associated with cirrhosis development in CHB patients include duration of diseases, familial history, route of infection (vertical infection), male gender, the level of HBsAg(higher than 1 000 COI), and HBV DNA level.

Influencing factors of hepatitis B virus related hepatocellular carcinoma patients without cirrhosis

Logistic Regression Analysis on Risk Factors of Hepatocellular Carcinoma Due to Hepatitis B Cirrhosis

Epidemiological and Clinical Analysis of 321 Patients with Hepatitis B Virus-related Hepatocellular Carcinoma in North China

Risk factors for hepatocellular carcinoma in cirrhosis: A comprehensive analysis from a decade-long study

[An Analysis of Clinical Characteristics and Risk Factors of Cirrhosis-Related Hepatocellular Carcinomas in Patients with Hepatitis C Virus Infection].

Evaluation of the clinical risk factors associated with liver cirrhosis in patients with chronic hepatitis B viral infection

Risk Factors for Hepatocellular Carcinoma in Cirrhotic Patients with Chronic Hepatitis B

Analysis of Clinical Characteristics of 415 Patiens with Primary hepatic carcinoma

Risk Factors for Combined Hepatocellular-Cholangiocarcinoma: A Hospital-Based Case-Control Study

Incidence And Predictors Of Hepatocellular Carcinoma In Chinese Hepatitis B Virus-Related Cirrhotic Patients Receiving Antiviral Therapy: A Retrospective Cohort Study

A case-control study on influencing factors of primary hepatic carcinoma

Factors Predicting Occurrence and Prognosis of Hepatitis-B-virus-related Hepatocellular Carcinoma

[Analysis of related factors for primary hepatic carcinoma caused by chronic hepatitis B and hepatitis C]

Long-term follow-up of cumulative incidence of hepatocellular carcinoma in hepatitis B virus patients without antiviral therapy

Contribution of Hepatitis B Virus Infection to the Aggressiveness of Primary Liver Cancer: A Clinical Epidemiological Study in Eastern China

Case- Control Study on Hepatitis Virus Infection, Alcohol Drinking, and Hepatocelluar Carcinoma

What is the Role of Family History in Hepatocellular Carcinoma Development in a Han Chinese Population?

Clinical characteristics and risk factors of hepatitis B virus-related cirrhosis in Chinese adults aged 40 years or younger: a retrospective study

Prevention of hepatocellular carcinoma in nonviral-related liver diseases.

A Case-Control Study of the Relationship Between Hepatitis B Virus DNA Level and Risk of Hepatocellular Carcinoma in Qidong, China

Study of effect factors for prognosis of chronic severe hepatitis B